Janusz Milanowski

907 total citations · 1 hit paper
11 papers, 722 citations indexed

About

Janusz Milanowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Janusz Milanowski has authored 11 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Janusz Milanowski's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (2 papers) and HER2/EGFR in Cancer Research (2 papers). Janusz Milanowski is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (2 papers) and HER2/EGFR in Cancer Research (2 papers). Janusz Milanowski collaborates with scholars based in Poland and Germany. Janusz Milanowski's co-authors include Rodryg Ramlau, Piotr Serwatowski, Georgy M. Manikhas, U. Gatzemeier, Johan Vansteenkiste, E. Kaukel, Joachim von Pawel, Jaromı́r Roubec, Aleksandra Szczęsna and A Płużańska and has published in prestigious journals such as Journal of Clinical Oncology, Cancers and Journal of Thoracic Oncology.

In The Last Decade

Janusz Milanowski

6 papers receiving 704 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

2007 706 citations U. Gatzemeier, A Płużańska et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Janusz Milanowski Poland	4	636	603	174	68	32	11	722
Kosei Tajima Japan	8	611 1.0×	529 0.9×	150 0.9×	98 1.4×	24 0.8×	15	706
Giovanni Palazzolo Italy	15	474 0.7×	528 0.9×	211 1.2×	85 1.3×	41 1.3×	47	786
B. E. Johnson United States	12	388 0.6×	359 0.6×	209 1.2×	101 1.5×	36 1.1×	17	534
Athina Agelidou Greece	14	580 0.9×	629 1.0×	146 0.8×	78 1.1×	35 1.1×	31	756
Henri Janicot France	12	464 0.7×	482 0.8×	162 0.9×	68 1.0×	58 1.8×	32	658
C. Zhou China	9	551 0.9×	449 0.7×	202 1.2×	153 2.3×	47 1.5×	50	660
Ryotaro Morinaga Japan	12	338 0.5×	318 0.5×	147 0.8×	82 1.2×	28 0.9×	27	496
Jane Bromund United States	9	467 0.7×	447 0.7×	127 0.7×	85 1.3×	22 0.7×	17	609
Bente Frimodt‐Moller United States	10	549 0.9×	527 0.9×	164 0.9×	166 2.4×	37 1.2×	24	766
Neelam Shah United States	4	584 0.9×	544 0.9×	200 1.1×	88 1.3×	12 0.4×	5	724

Countries citing papers authored by Janusz Milanowski

Since Specialization

Citations

This map shows the geographic impact of Janusz Milanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janusz Milanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janusz Milanowski more than expected).

Fields of papers citing papers by Janusz Milanowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janusz Milanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janusz Milanowski. The network helps show where Janusz Milanowski may publish in the future.

Co-authorship network of co-authors of Janusz Milanowski

This figure shows the co-authorship network connecting the top 25 collaborators of Janusz Milanowski. A scholar is included among the top collaborators of Janusz Milanowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janusz Milanowski. Janusz Milanowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Krawczyk, Paweł, Kamila Wojas‐Krawczyk, Andrzej Tysarowski, et al.. (2025). Effectiveness of First-Line Treatment with Anaplastic Lymphoma Kinase and ROS1 Protoncogene Inhibitors in Non-Small Cell Lung Cancer Patients—Real-World Evidence of Two Polish Cancer Centers. Cancers. 17(7). 1253–1253.

Nicoś, Marcin, Barbara Kuźnar-Kamińska, Izabela Chmielewska, et al.. (2025). MA10.04 Low-Pass Wgs Reveals Clonal Evolution of CNAs Associated With Response to the First-Line Immunotherapy or Chemoimmunotherapy in NSCLC Patients. Journal of Thoracic Oncology. 20(10). S96–S97.

Mańdziuk, Sławomir, et al.. (2015). Remission of advanced EGFR‑positive lung adenocarcinoma after short and intermittent erlotinib therapy. Polskie Archiwum Medycyny Wewnętrznej. 125(5). 381–382.

Krawczyk, Paweł, Radosław Mlak, Tomasz Powrózek, et al.. (2012). Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer. Współczesna Onkologia. 5(5). 401–406. 7 indexed citations

Ramlau, Rodryg, Tomasz Powrózek, Kamila Wojas‐Krawczyk, et al.. (2012). The detection of EGFR mutations in patients with non-small cell lung cancer in selected molecular diagnostics centers in Poland Wykrywalność mutacji w genie EGFR u chorych na niedrobnokomórkowego raka płuca w wybranych ośrodkach w Polsce zaangażowanych w diagnostykę molekularną.

Mlak, Radosław, Paweł Krawczyk, & Janusz Milanowski. (2010). Czynniki biochemiczne i genetyczne w diagnostyce i prognozowaniu przebiegu chorób nowotworowych. Via Medica Journals.

Wojas‐Krawczyk, Kamila, Sylwia Chocholska, Anna Góra, et al.. (2009). CYP1A1, GSTT1, and GSTM1 Polymorphisms and Lung Cancer in Eastern Poland. 1 indexed citations

Gatzemeier, U., A Płużańska, Aleksandra Szczęsna, et al.. (2007). Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial. Journal of Clinical Oncology. 25(12). 1545–1552. 706 indexed citations breakdown →

Mańdziuk, Sławomir, et al.. (2003). Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy.. PubMed. 58(1). 149–53. 4 indexed citations

10.

Mańdziuk, Sławomir, et al.. (2003). Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin.. PubMed. 58(1). 154–7. 1 indexed citations

11.

Mańdziuk, Sławomir, et al.. (2001). Expression of p21 and bcl-2 proteins and p53 mRNA in surgically resected preparations of non-small cell lung cancer (stage IIIA) after etoposide and cisplatin chemotherapy.. PubMed. 39 Suppl 2. 175–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact